Search Results - "H. E Kohrt"

Systematic review: lamivudine prophylaxis for chemotherapy‐induced reactivation of chronic hepatitis B virus infection by KOHRT, H. E., OUYANG, D. L., KEEFFE, E. B.

“…Summary Background  Reactivation of hepatitis B virus infection in asymptomatic hepatitis B surface antigen carriers undergoing chemotherapy or…”
Get full text

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats by Walters, M J, Ebsworth, K, Berahovich, R D, Penfold, M E T, Liu, S-C, Al Omran, R, Kioi, M, Chernikova, S B, Tseng, D, Mulkearns-Hubert, E E, Sinyuk, M, Ransohoff, R M, Lathia, J D, Karamchandani, J, Kohrt, H E K, Zhang, P, Powers, J P, Jaen, J C, Schall, T J, Merchant, M, Recht, L, Brown, J M

“…Background: In experimental models of glioblastoma multiforme (GBM), irradiation (IR) induces local expression of the chemokine CXCL12/SDF-1, which promotes…”
Get full text

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia by Pollyea, D A, Kohrt, H E, Gallegos, L, Figueroa, M E, Abdel-Wahab, O, Zhang, B, Bhattacharya, S, Zehnder, J, Liedtke, M, Gotlib, J R, Coutre, S, Berube, C, Melnick, A, Levine, R, Mitchell, B S, Medeiros, B C

“…Acute myeloid leukemia (AML) is a disease of the elderly. Poor outcomes with standard therapies necessitate novel approaches. Outpatient regimens sufficiently…”
Get full text

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use by Kao, D. P., Kohrt, H. E., Kugler, J.

“…Background  Sitagliptin is a new oral glucose‐lowering medication that acts via the incretin hormone system. The most common side‐effects are headache and…”
Get full text

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning by Rezvani, A R, Kanate, A S, Efron, B, Chhabra, S, Kohrt, H E, Shizuru, J A, Laport, G G, Miklos, D B, Benjamin, J E, Johnston, L J, Arai, S, Weng, W-K, Negrin, R S, Strober, S, Lowsky, R

“…We describe 47 patients with lymphoma and failed prior autologous hematopoietic cell transplantation (HCT) who received TLI-ATG (anti-thymocyte globulin)…”
Get full text

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy by Makkouk, A., Sundaram, V., Chester, C., Chang, S., Colevas, A.D., Sunwoo, J.B., Maecker, H., Desai, M., Kohrt, H.E.

“…In the era of personalized cancer medicine, identifying techniques for effectively matching patients to efficacious treatments is a critical step in the…”
Get full text

Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer by T.S. Uldrick, M.A. ‘Mac’ Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan

Get full text

Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses by KOHRT, Holbrook E, SHU, Chenn-Tsen, STUGE, Tor B, HOLMES, Susan P, WEBER, Jeffrey, LEE, Peter P

“…It is increasingly recognized that cells within an antigen-specific CD8 T-cell population may be diverse in recognition efficiency for target, which may…”
Get full text

Treatment advances have not improved the early death rate in acute promyelocytic leukemia by MCCLELLAN, James Scott, KOHRT, Holbrook E, COUTRE, Steven, GOTLIB, Jason R, MAJETI, Ravindra, ALIZADEH, Ash A, MEDEIROS, Bruno C

“…Early mortality in acute promyelocytic leukemia has been reported to occur in less than 10% of patients treated in clinical trials. This study reports the…”
Get full text

Immunotransplant for mantle cell lymphoma: Phase I/II study preliminary results by Brody, J., Advani, R., Weng, W., Czerwinski, D., Alizadeh, A. A., Kohrt, H. E., Negrin, R., Levy, R.

“…Abstract only…”
Get full text

CD137 stimulation of natural killer cells to enhance the antilymphoma activity of rituximab by Kohrt, H. E., Houot, R., Goldstein, M., Weiskopf, K., Chen, L., Tedder, T., Levy, R.

“…Abstract only…”
Get full text

An interactive statistical imaging system and pilot application to characterize axillary lymph nodes in breast cancer by Kohrt, H. E., Kapelner, A., Holmes, S., Lee, P. P.

“…Abstract only…”
Get full text

Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease by Kohrt, H. E., Advani, R., Hoppe, R., Rosenberg, S., Horning, S., Lee, P. P.

“…Abstract only 8573 Background: Multiple translational efforts in HD are actively investigating augmentation of the anti-tumor immune response by stimulating…”
Get full text

Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL by Shepard, D. D., Kohrt, H. E., Rosenblat, T. L., Jurcic, J. G., Park, J. H., Goldman, A., Dalal, J. S., Maslak, P. G., Jakubowski, A. A., Klimek, V., Berman, E., Nand, S., Coutre, S. E., Tallman, M. S., Erba, H. P.

“…Abstract only…”
Get full text

Sequential azacitidine and lenalidomide in elderly acute myeloid leukemia: completed results of the phase I study by Pollyea, D. A., Kohrt, H. E., Gallegos, L., Zhang, B., Figueroa, M., Melnick, A., Berube, C., Coutre, S. E., Gotlib, J. R., Zehnder, J. L., Liedtke, M., Mitchell, B. S., Medeiros, B. C.

“…Abstract only…”
Get full text

An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients by Pollyea, D. A., Kohrt, H. E., Rajwanshi, R., Gallegos, L., Berube, C., Coutre, S. E., Gotlib, J. R., Liedtke, M., Mitchell, B. S., Medeiros, B. C.

“…Abstract only…”
Get full text

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer by Kohrt, Holbrook E, Nouri, Navid, Nowels, Kent, Johnson, Denise, Holmes, Susan, Lee, Peter P

“…While lymph node metastasis is among the strongest predictors of disease-free and overall survival for patients with breast cancer, the immunological nature of…”
Get full text

Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment by Rajasekaran, Narendiran, Chester, Cariad, Yonezawa, Atsushi, Zhao, Xing, Kohrt, Holbrook E

“…The therapeutic efficacy of some anti-tumor monoclonal antibodies (mAbs) depends on the capacity of the mAb to recognize the tumor-associated antigen and…”
Get full text

Predicting non-sentinel lymph node involvement in breast cancer patients by Kohrt, H. E., Olshen, R. A., Goodson, W. H., Rouse, R. V., Bailey, L., Philben, V., Dirbas, F. M., Stockdale, F. E., Carlson, R. W., Jeffrey, S. S.

“…Abstract only 531 Background: Current convention is to perform a completion axillary lymph node dissection (ALND) for invasive breast cancer (BC) patients…”
Get full text

Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa by Kohrt, Brandon A, Hruschka, Daniel J, Kohrt, Holbrook E, Panebianco, Nova L, Tsagaankhuu, G

“…This study discusses quality of life in post-socialist Mongolia. Yadargaa, a fatigue-related illness in traditional Mongolian medicine, results from lifestyle…”
Get full text